• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于证据的双相抑郁治疗更新:我们处于什么位置?

An update of evidence-based treatment of bipolar depression: where do we stand?

机构信息

3rd Department of Psychiatry, School of Medicine, Aristotle University of Thessaloniki, 6 Odysseos Str. (Parodos Ampelonon Str.), Pylaia, Thessaloniki, Greece.

出版信息

Curr Opin Psychiatry. 2010 Jan;23(1):19-24. doi: 10.1097/YCO.0b013e328333e132.

DOI:10.1097/YCO.0b013e328333e132
PMID:19901836
Abstract

PURPOSE OF REVIEW

The current article attempts to summarize the current status of our knowledge and practice in the treatment of bipolar depression and suggests future directions.

RECENT FINDINGS

Our knowledge about lithium solidly supports its usefulness during all phases of bipolar illness and its specific effectiveness on suicidal prevention. Specific second-generation antipsychotics could constitute a promising option for treating bipolar depression, although only limited data exist so far. Anticonvulsants appear to possess a broad spectrum of effectiveness, including mixed dysphoric and rapid-cycling forms. Lamotrigine may be preferably effective in the treatment of depression but not mania. The usefulness of antidepressants in bipolar depression is controversial. The first line of psychosocial intervention in bipolar depression is psychoeducation, family-focused psychoeducation and cognitive-behavioral therapy. Electroconvulsive therapy and transcranial magnetic stimulation are options for refractory patients. Accumulated knowledge so far indicates that bipolar patients need continuous administration of an antimanic agent even during the acute depressive phase.

SUMMARY

The development of rationalized 'combination treatment' guidelines is essential today, as it seems that the vast majority of patients do poorly on monotherapy and need complex pharmacotherapies. Although our knowledge is indeed limited, the development of some kind of guidelines for polypharmacy is possible and should be done as soon as possible.

摘要

目的综述

本文旨在总结目前我们在双相抑郁治疗方面的知识和实践现状,并提出未来的研究方向。

最新发现

目前我们充分了解锂盐在双相障碍各个阶段的有效性,以及其在预防自杀方面的特殊作用。某些第二代抗精神病药物有望成为治疗双相抑郁的有效选择,尽管目前相关数据有限。抗惊厥药似乎具有广泛的疗效,包括治疗混合性抑郁和快速循环发作。拉莫三嗪可能对治疗抑郁更有效,但对躁狂无效。抗抑郁药在双相抑郁中的作用存在争议。双相抑郁的一线心理社会干预措施是心理教育、以家庭为中心的心理教育和认知行为疗法。对于难治性患者,电抽搐治疗和经颅磁刺激是可选治疗方法。目前的研究结果表明,大多数双相患者在急性抑郁期也需要持续使用抗躁狂药物。

总结

目前需要制定合理的“联合治疗”指南,因为大多数患者单药治疗效果不佳,需要复杂的药物治疗。尽管我们的知识确实有限,但制定某种多药治疗指南是可行的,并且应该尽快进行。

相似文献

1
An update of evidence-based treatment of bipolar depression: where do we stand?基于证据的双相抑郁治疗更新:我们处于什么位置?
Curr Opin Psychiatry. 2010 Jan;23(1):19-24. doi: 10.1097/YCO.0b013e328333e132.
2
Treatment of bipolar depression: an update.双相抑郁的治疗:最新进展
J Affect Disord. 2008 Jul;109(1-2):21-34. doi: 10.1016/j.jad.2007.10.016. Epub 2007 Nov 26.
3
Treatments for late-life bipolar disorder.老年双相情感障碍的治疗方法。
Am J Geriatr Pharmacother. 2006 Dec;4(4):347-64. doi: 10.1016/j.amjopharm.2006.12.007.
4
Treatment guidelines for bipolar disorder: a critical review.双相情感障碍治疗指南:一项批判性综述。
J Affect Disord. 2005 May;86(1):1-10. doi: 10.1016/j.jad.2005.01.004.
5
Medicating mood with maintenance in mind: bipolar depression pharmacotherapy.在考虑维持治疗的情况下用药治疗心境:双相抑郁的药物治疗
Bipolar Disord. 2009 Jun;11 Suppl 2:55-76. doi: 10.1111/j.1399-5618.2009.00711.x.
6
The Expert Consensus Guideline Series: Medication Treatment of Bipolar Disorder 2000.《专家共识指南系列:双相情感障碍的药物治疗(2000年版)》
Postgrad Med. 2000 Apr;Spec No:1-104.
7
Bipolar II disorder: current and future treatment options.双相II型障碍:当前及未来的治疗选择
Ann Clin Psychiatry. 2006 Oct-Dec;18(4):259-66. doi: 10.1080/10401230600948480.
8
Anticonvulsants in bipolar disorder.双相情感障碍中的抗惊厥药。
Psychiatr Clin North Am. 2005 Jun;28(2):301-23. doi: 10.1016/j.psc.2005.02.004.
9
Rational polypharmacy in the bipolar affective disorders.双相情感障碍中的合理联合用药
Epilepsy Res Suppl. 1996;11:153-80.
10
Efficacy of newer anticonvulsant medications in bipolar spectrum mood disorders.新型抗惊厥药物在双相谱系心境障碍中的疗效
J Clin Psychiatry. 2003;64 Suppl 8:9-14.

引用本文的文献

1
Challenges in the development of treatment guidelines for bipolar disorder.双相情感障碍治疗指南制定中的挑战。
Front Psychiatry. 2025 Jun 10;16:1564004. doi: 10.3389/fpsyt.2025.1564004. eCollection 2025.
2
Agranulocytosis Associated With Psychiatric Polypharmacy: Lessons Learned From a Clinical Case.与精神科联合用药相关的粒细胞缺乏症:从一例临床病例中吸取的教训。
Cureus. 2024 Mar 22;16(3):e56701. doi: 10.7759/cureus.56701. eCollection 2024 Mar.
3
Comparison of the efficacy of venlafaxine and bupropion in the treatment of depressive episode in patients with bipolar II disorder.
文拉法辛与安非他酮治疗双相II型障碍患者抑郁发作疗效的比较。
J Family Med Prim Care. 2023 Mar;12(3):440-445. doi: 10.4103/jfmpc.jfmpc_1258_22. Epub 2023 Mar 17.
4
Lithium bidirectionally regulates depression- and mania-related brain functional alterations without worsening cognitive function in patients with bipolar disorder.锂盐双向调节双相情感障碍患者与抑郁和躁狂相关的脑功能改变,且不会恶化其认知功能。
Front Psychiatry. 2022 Sep 15;13:963005. doi: 10.3389/fpsyt.2022.963005. eCollection 2022.
5
Lithium produces bi-directionally regulation of mood disturbance, acts synergistically with anti-depressive/-manic agents, and did not deteriorate the cognitive impairment in murine model of bipolar disorder.锂对心境障碍具有双向调节作用,与抗抑郁/抗躁狂药物具有协同作用,并且不会恶化双相情感障碍小鼠模型的认知障碍。
Transl Psychiatry. 2022 Sep 2;12(1):359. doi: 10.1038/s41398-022-02087-6.
6
Intranasal esketamine use in bipolar disorder: A case report.鼻内使用艾司氯胺酮治疗双相情感障碍:一例报告。
Ment Health Clin. 2021 Jul 16;11(4):259-262. doi: 10.9740/mhc.2021.07.259. eCollection 2021 Jul.
7
Critical Predictors for the Early Detection of Conversion From Unipolar Major Depressive Disorder to Bipolar Disorder: Nationwide Population-Based Retrospective Cohort Study.单相重度抑郁症转变为双相情感障碍早期检测的关键预测因素:基于全国人口的回顾性队列研究。
JMIR Med Inform. 2020 Apr 3;8(4):e14278. doi: 10.2196/14278.
8
The CINP Guidelines on the Definition and Evidence-Based Interventions for Treatment-Resistant Bipolar Disorder.CINP 关于治疗抵抗性双相情感障碍的定义和基于证据的干预措施指南。
Int J Neuropsychopharmacol. 2020 Apr 23;23(4):230-256. doi: 10.1093/ijnp/pyz064.
9
The Therapeutic Potential of Mangosteen Pericarp as an Adjunctive Therapy for Bipolar Disorder and Schizophrenia.山竹果皮作为双相情感障碍和精神分裂症辅助治疗手段的治疗潜力
Front Psychiatry. 2019 Mar 13;10:115. doi: 10.3389/fpsyt.2019.00115. eCollection 2019.
10
The International College of Neuropsychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 1: Background and Methods of the Development of Guidelines.国际神经精神药理学学会(CINP)成人双相情感障碍治疗指南(CINP-BD-2017),第 1 部分:指南制定的背景和方法。
Int J Neuropsychopharmacol. 2017 Feb 1;20(2):98-120. doi: 10.1093/ijnp/pyw091.